SFX by Ex Libris Inc.

Title:	MicroRNA-132–mediated loss of p120RasGAP activates the endothelium to facilitate pathological angiogenesis
Source:	Nature Medicine [1078-8956] Anand, Sudarshan yr:2010

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Strieter, Robert M. "Masters of angiogenesis." Nature medicine 11.9 (2005): 925-927.
description	2.	Murphy, E. "Nanoparticle-mediated drug delivery to tumor vasculature suppresses metastasis." Proceedings of the National Academy of Sciences of the United States of America 105.27 (2008): 9343-9348.
description	3.	Fischer, C. "VEGF inhibitors make blood." Nature medicine 12.7 (2006): 732-4.
description	4.	Uhlenhaut, Susanne H. "Somatic sex reprogramming of adult ovaries to testes by FOXL2 ablation." Cell 139.6 (2009): 1130-1142.
description	5.	Camps, Montserrat, M. "Blockade of PI3Kγ suppresses joint inflammation and damage in mouse models of rheumatoid arthritis." Nature medicine 11.9: 936-943.
description	6.	Kieran MW, Mark W W. "Angiogenesis inhibitors and hypoxia." Nature medicine 9.9 (2003): 1104-1104.
description	7.	Smith, Lois E H E. "A radically twisted lipid regulates vascular death." Nature medicine 11.12 (2006): 1275-6.
description	8.	Hodivala-Dilke, K. "Nanoparticle-mediated gene delivery to tumour neovasculature." Trends in molecular medicine 9.1 (2003): 2-4.
description	9.	Sengupta, S. "Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system." Nature 436.7050 (2005): 568-572.
description	10.	Jiang, W. "Nanoparticle-mediated cellular response is size-dependent." Nature nanotechnology 3.3 (2008): 145-150.
description	11.	De, A. "The role of the EGFR signaling in tumor microenvironment." Journal of cellular physiology 214.3 (2008): 559-67.
description	12.	Minamitake, Y. "Biodegradable long-circulating polymeric nanospheres." Science 263.5153: 1600-1603.
description	13.	Berkowitz, J. "Harnessing structure-activity relationship to engineer a cisplatin nanoparticle for enhanced antitumor efficacy." Proceedings of the National Academy of Sciences of the United States of America 107.28 (2010): 12435-12440.
description	14.	Stefanick, Jared F. "A Systematic Analysis of Peptide Linker Length and Liposomal Polyethylene Glycol Coating on Cellular Uptake of Peptide-Targeted Liposomes." ACS nano 7.4 (2013): 2935-2947.
description	15.	Kiziltepe, T. "Rationally engineered nanoparticles target multiple myeloma cells, overcome cell-adhesion-mediated drug resistance, and show enhanced efficacy in vivo." Blood Cancer Journal 2.4 (2012).
description	16.	Langer, R. "Drug delivery and targeting." Nature 392.6679 (1998): 5-10.
description	17.	Chithrani, B. a. "Elucidating the Mechanism of Cellular Uptake and Removal of Protein-Coated Gold Nanoparticles of Different Sizes and Shapes." Nano letters 7.6 (2007): 1542-1550.
description	18.	Behra, R. "Nanoecotoxicology: Nanoparticles at large." Nature 3 (2008): 253-.
description	19.	Tam, Betty Y Y Y. "VEGF modulates erythropoiesis through regulation of adult hepatic erythropoietin synthesis." Nature medicine 12.7 (2006): 793-800.
description	20.	Soppimath, K S S. "Biodegradable polymeric nanoparticles as drug delivery devices." Journal of controlled release 70.1-2 (2001): 1-20.